Aquestive Therapeutics, Inc.
AQST
$4.39
-$0.08-1.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 110.73M | 121.17M | 129.06M | 60.54M | 68.66M |
| Total Receivables | 6.87M | 17.76M | 11.80M | 11.86M | 10.44M |
| Inventory | 8.07M | 6.17M | 7.88M | 8.13M | 7.20M |
| Prepaid Expenses | 4.52M | 4.17M | 2.93M | 1.20M | 2.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 130.18M | 149.27M | 151.67M | 81.72M | 89.17M |
|
|
|||||
| Total Current Assets | 130.18M | 149.27M | 151.67M | 81.72M | 89.17M |
| Net Property, Plant & Equipment | 8.31M | 8.51M | 8.69M | 8.77M | 8.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.64M | 2.64M | 3.20M | 3.21M | 4.22M |
| Total Assets | 141.13M | 160.43M | 163.56M | 93.70M | 102.23M |
|
|
|||||
| Total Accounts Payable | 11.89M | 29.86M | 10.87M | 11.95M | 12.28M |
| Total Accrued Expenses | 3.45M | 5.03M | 5.69M | 5.37M | 3.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.32M | 10.63M | 6.93M | 3.75M | 567.00K |
| Total Finance Division Other Current Liabilities | 2.09M | 2.09M | 2.09M | 2.09M | 2.05M |
| Total Other Current Liabilities | 2.09M | 2.09M | 2.09M | 2.09M | 2.05M |
| Total Current Liabilities | 31.75M | 47.61M | 25.57M | 23.16M | 18.30M |
|
|
|||||
| Total Current Liabilities | 31.75M | 47.61M | 25.57M | 23.16M | 18.30M |
| Long-Term Debt | 24.99M | 27.41M | 29.82M | 31.71M | 33.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.26M | 4.45M | 4.63M | 4.80M | 4.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 114.17M | 114.62M | 107.65M | 106.62M | 106.30M |
| Total Liabilities | 175.18M | 194.09M | 167.67M | 166.29M | 163.16M |
|
|
|||||
| Common Stock & APIC | 421.00M | 413.34M | 411.03M | 327.10M | 325.21M |
| Retained Earnings | -455.06M | -447.00M | -415.14M | -399.69M | -386.14M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.05M | -33.66M | -4.11M | -72.59M | -60.93M |
|
|
|||||